Search

IntroductionMaternal diet during pregnancy has been linked to offspring allergy risk and it could represent a potential target for allergy prevention. The Mediterranean Diet (MD) is considered one of the healthiest dietary models. Randomized-controlled trials on the effect of MD in preventing pediatric allergic diseases are still needed.Methods and analysisThe Mediterranean Diet during Pregnancy study (PREMEDI) will be a 9-month multi-center, randomized-controlled, parallel groups, prospective trial. Healthy women (20–35 years) at their first trimester of pregnancy at risk for atopy baby, will be randomly allocated to Group 1 (standard obstetrical and gynecological follow-up and nutritional counseling to promote MD) or Group 2 (standard obstetrical and gynecological follow-up alone). 138 mother-child pair per group will be needed to detect a reduction in cumulative incidence of ≥1 allergic disease at 24 months of age. The primary study aim will be the evaluation of the occurrence of allergic disorders in the first 24 months of life. The secondary aims will be the evaluation of maternal weight gain, pregnancy/perinatal complications, growth indices and occurrence of other chronic disorders, mother-child pair adherence to MD and gut microbiome features, breastfeeding duration and breast milk composition, epigenetic modulation of genes involved in immune system, and metabolic pathways in the offspring.Ethics and disseminationThe study protocol has been approved by the Ethics Committee of the University of Naples Federico II (number 283/21) and it will be conducted in accordance with the Helsinki Declaration (Fortaleza revision, 2013), the Good Clinical Practice Standards (CPMP/ICH/135/95), the Italian Decree-Law 196/2003 regarding personal data and the European regulations on this subject. The study has been registered in the Clinical Trials Protocol Registration System.Clinical trial registration[http://clinicaltrials.gov], identifier [NCT05119868].

BackgroundPregnant women, especially those with comorbidities, compared to those non-pregnant, have higher risk of developing a severe form of COVID-19. However, COVID-19 vaccine uptake is very low among them.MethodsAn anonymous questionnaire was administered to randomly selected women 18 years of age that were currently pregnant or had just given birth between September 2021 and May 2022 in the geographic area of Naples. Vaccine hesitancy was assessed using the vaccine hesitancy scale (VHS).ResultsA total of 385 women participated. Women who had not been infected by SARS-CoV-2 and who needed information about vaccination against COVID-19 had a higher perceived risk of being infected with SARS-CoV-2. More than half (54.3%) of the women were very afraid of the potential side effects of the COVID-19 vaccination on the fetus. There was higher concern of the side effects of the vaccine on the fetus among those who did not have a graduate degree, those with high-risk pregnancy, those who had not been infected by SARS-CoV-2, those who were more concerned that they could be infected by SARS-CoV-2, those who did not know that this vaccination was recommended for them, and those trusting mass media/internet/social networks for information. Only 21.3% were vaccinated when pregnant, mostly women with a university degree, those who had been infected by SARS-CoV-2 before pregnancy, those who did not need information, and those who acquired information about the vaccination from gynecologists. Almost three-quarters (71.9%) were willing to receive the vaccination and those more likely were those with a university degree, those who have had at least one relative/cohabitant partner/friend who had been infected by SARS-CoV-2, those who were more concerned that they could be infected by SARS-CoV-2, and those who were not extremely concerned of the side effects of the vaccine on the fetus. A total of 86.4% were highly hesitant. Highly hesitant were respondents who did not get a graduate degree, those less concerned that they could be infected by SARS-CoV-2, and those trusting mass media/internet/social networks for information.ConclusionPublic health efforts and education campaigns for pregnant women are needed for changing their perception patterns and for supporting gynecologists in promoting the uptake of this vaccination.

The ca. 2.96 Ga Dominion Group (DG) preserves the first subaerial volcano-sedimentary succession on the Kaapvaal Craton. Based on field and core observations, this study provides revised stratigraphic logs and geological maps from the area around Ottosdal that refine the understanding of the stratigraphic and tectonic evolution of these ancient rocks. Fluvial sandstone and conglomerate of the Rhenosterspruit Formation (RsF) were deposited on granite basement, followed by andesitic to basaltic volcanic rocks of the Rhenosterhoek Formation (RhF). These amygdaloidal andesitic to basaltic lava units show fragmentation around lava flows that may represent an indication of prevalent subaerial environment. However, local hyaloclastite and pillow lava units indicate periodic aqueous conditions. The Syferfontein Formation (SF) has the most extensive exposures in the Ottosdal area and represents the youngest volcanic unit of the DG. The porphyritic and spherulitic volcanic rocks tell a story of subaerial volcanism interspersed with periods of lacustrine deposition of sandstone and shale. The Witwatersrand Supergroup (WSG) overlies the DG along an angular unconformity. Folding affected the succession of the DG, WSG and the Ventersdorp Supergroup (Rietgat Formation). This event is reflected in small-scale folds and mullion structures in the central part of the study area and by larger scale north-north-west-south-southeast-striking anticlines and synclines. Folding was accompanied by northwest-southeast-striking thrust faulting, either during or shortly after the formation of the Ventersdorp Supergroup. In the study area, post-Ventersdorp deformation is restricted to east-northeast-west-southwest-striking faults. [ABSTRACT FROM AUTHOR]